This is the authors' abstract. We don't add key points for this paper.
Long-term high-fat diet (HFD) strongly induces colon injury and metabolic disorders, with ferroptosis as a key mechanism. Sinensetin, a natural polymethoxyflavone, exhibits exceptional bioactivity; however, its potential to ameliorate HFD-induced colonic ferroptosis and underlying targeted mechanisms remains unclear. This study investigated sinensetin’s protective effects and modulation of TRPV4/Ca2+ signaling. In vivo and in vitro, sinensetin restored impaired intestinal morphology, decreased permeability, and upregulated tight junction proteins. It suppressed lipid peroxidation and iron overload by reducing ROS and Fe2+ accumulation. Antiferroptotic effects included increased glutathione peroxidase 4 (GPX4), ferroportin (FPN), and ferritin heavy chain (FTH), and decreased ACSL4 and transferrin receptor 1 (TfR1). Mechanistically, sinensetin negatively modulated TRPV4/Ca2+ signaling, preventing intracellular Ca2+ overload; a TRPV4 agonist reversed these benefits. These findings reveal a novel mechanism by which this citrus-derived compound mitigates HFD-induced intestinal damage via TRPV4/Ca2+-mediated ferroptosis inhibition, offering a potential preventive and therapeutic candidate for metabolic intestinal diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: